You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Some of the firms will receive money to speed up test development, while others will use the funds to expand their testing and manufacturing capacity.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.
